Serum Adiponectin Levels in Advanced-Stage Parkinson's Disease Patients

Patients with advanced Parkinson's disease (PD) experience body weight loss and reductions in the most common cardiovascular risk factors. At present, the pathogenetic mechanisms involved have not been elucidated. Increased serum concentrations of adiponectin, which possesses antiatherogenic an...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Cassani, Erica, Cancello, Raffaella, Cavanna, Ferruccio, Maestrini, Sabrina, Di Blasio, Anna Maria, Liuzzi, Antonio, Pezzoli, Gianni, Barichella, Michela
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE-Hindawi Access to Research 2011
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3135047/
https://ncbi.nlm.nih.gov/pubmed/21766000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4061/2011/624764
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg